Back

Opening question.

27 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Do we need PCSK9 inhibitors in post-MI patients? Drug therapy ESC Premium Access ESC Congress 2017

7 More presentations in this session

Presentation thumbnail
Positioning of the topic - The PCSK9 story .. so far
Professor F. Mach (Geneva, CH)
Slides Video
Presentation thumbnail
Do we need PCSK9 inhibitors in post-MI patients? PRO
Professor M. Sabatine (Boston, US)
Slides Video
Presentation thumbnail
Do we need PCSK9 inhibitors in post-MI patients? CON
Professor H. Drexel (Feldkirch, AT)
Slides Video
Presentation thumbnail
Do we need PCSK9 inhibitors in post-MI patients? Rebuttal PRO
Professor M. Sabatine (Boston, US)
Video
Presentation thumbnail
Do we need PCSK9 inhibitors in post-MI patients? Rebuttal CON
Professor H. Drexel (Feldkirch, AT)
Video

Access the full session

Session thumbnail
Do we need PCSK9 inhibitors in post-MI patients?

The Event

Event poster

ESC Congress 2017

27 August 2017 00:00 CET
You may be interested in
thumbnail
Congress Presentation
Questions & answers.
4 April 2022
thumbnail
Congress Presentation
Comparison of the effects of pre-dilatation with conventional versus larger balloon sizes on clinical outcomes in transcatheter aortic valve implantation with self-expandable valves
31 August 2024
thumbnail
Congress Presentation
PCI - get ready for the session
28 August 2023
thumbnail
Congress Presentation
Discussion.
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources